- Drug Pipelines
- January 2022
- 30 Pages
Global
From €458EUR$500USD£389GBP
Combivir is a combination antiretroviral medication used to treat HIV/AIDS. It is a fixed-dose combination of two drugs, lamivudine and zidovudine, both of which are nucleoside reverse transcriptase inhibitors (NRTIs). Combivir is used to reduce the amount of HIV in the body, allowing the immune system to recover and preventing the progression of HIV to AIDS. It is usually prescribed in combination with other antiretroviral drugs.
Combivir is a widely used antiretroviral medication, and is available in many countries around the world. It is generally well tolerated, with few side effects. However, it is not suitable for everyone, and should be used with caution in people with certain medical conditions.
Companies in the Combivir market include GlaxoSmithKline, ViiV Healthcare, Mylan, and Teva Pharmaceuticals. Show Less Read more